Fibromyalgia: Epidemiology and Risk Factors, a Population-based Case-control Study in Damascus, Syria

Overview

Journal BMC Rheumatol

Specialty Rheumatology

Date 2022 Oct 31

PMID 36310163

Authors

Mhd Amin Alzabibi

Mosa Shibani

Tamim Alsuliman

Hlma Ismail

Suja Alasaad

Andre Torbey

Abdallah Altorkmani

Bisher Sawaf

Rita Ayoub

Naram Khalayli

Mayssoun Kudsi

Affiliations

Soon will be listed here.

Abstract

Background: Fibromyalgia is a chronic disease with a high burden. We aim to be the first to investigate the prevalence of fibromyalgia (FM) in Syria and assess its risk factors.

Methods: A self-reported questionnaire was distributed to the public to identify fibromyalgia patients using the American College of Rheumatology (ACR) 2010 modified criteria. Identified cases were matched using age with controls free from rheumatic disorders that were randomly sampled from the same population.

Results: Out of 2966 participants, 350 (11.8%) satisfied the diagnostic criteria. Of these, only 29 (8.2%) were previously diagnosed by a physician, 239 (68.3%) were females, and 69 (19.71%) were diagnosed with depression. Female sex (OR = 1.31), diagnosis of major depressive disorder (OR = 2.62), irritable bowel syndrome (OR = 1.8), and Restless legs syndrome (OR = 1.72) were associated with a higher likelihood of fibromyalgia.

Conclusion: Our study revealed one of the highest prevalence rates of fibromyalgia ever reported in the general population. Efforts must be intensified to increase awareness about this disease in Syrian society as well as among healthcare providers.

Citing Articles

Exploring the Overlooked Depression, Anxiety, Insomnia and Fibromyalgia Syndrome Burden in Arab Women with Type 2 Diabetes: New Avenues for Chronic Disease Management.

Gammoh O, Alqudah A, Alswidan M, Abu Shwiemeh L, Abu Shaikh H, Massad T Medicina (Kaunas). 2024; 60(8).

PMID: 39202585 PMC: 11356769. DOI: 10.3390/medicina60081304.

The Risk of Severe Fibromyalgia, Depression, Anxiety, and Insomnia Symptoms in Arab Women: An Implication of Self-Medication with Analgesics? A Cross-Sectional Study.

Gammoh O, Al-Ameri M, Altaani G, Al-Smadi A, Al-Zegoul R, Massad T Medicina (Kaunas). 2024; 60(7).

PMID: 39064494 PMC: 11278719. DOI: 10.3390/medicina60071065.

Prevalence of fibromyalgia and irritable bowel syndrome and its association with studying medicine, a cross-sectional study in Al-Baath University, Syria.

Daher M, Abbas S, Asaad Z, Khalil K, Jadid G Brain Behav. 2024; 14(3):e3445.

PMID: 38468467 PMC: 10928353. DOI: 10.1002/brb3.3445.

Effect of Steroids on Patients With Fibromyalgia/Chromic Widespread Pain: An Observational Study.

Gurunathan O, Chellapandian E, Thirunavukkarasu S, Thermalingem S, Eswaradass P Cureus. 2024; 16(2):e53736.

PMID: 38465077 PMC: 10920059. DOI: 10.7759/cureus.53736.

Sexuality in Women with Fibromyalgia Syndrome: A Metasynthesis of Qualitative Studies.

Granero-Molina J, Jimenez-Lasserrotte M, Dobarrio-Sanz I, Correa-Casado M, Ramos-Rodriguez C, Romero-Alcala P Healthcare (Basel). 2023; 11(20).

PMID: 37893837 PMC: 10606292. DOI: 10.3390/healthcare11202762.

References

Branco J, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M . Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2009; 39(6):448-53. DOI: 10.1016/j.semarthrit.2008.12.003. View

Adams L, Turk D . Psychosocial factors and central sensitivity syndromes. Curr Rheumatol Rev. 2015; 11(2):96-108. PMC: 4728142. DOI: 10.2174/1573397111666150619095330. View

Wang J, Sung F, Men M, Wang K, Lin C, Kao C . Bidirectional association between fibromyalgia and gastroesophageal reflux disease: two population-based retrospective cohort analysis. Pain. 2017; 158(10):1971-1978. DOI: 10.1097/j.pain.0000000000000994. View

White K, Speechley M, Harth M, Ostbye T . The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999; 26(7):1570-6. View

Trouvin A, Perrot S . New concepts of pain. Best Pract Res Clin Rheumatol. 2019; 33(3):101415. DOI: 10.1016/j.berh.2019.04.007. View

Wolfe F, Smythe H, Yunus M, Bennett R, Bombardier C, Goldenberg D . The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33(2):160-72. DOI: 10.1002/art.1780330203. View

Wolfe F, Clauw D, Fitzcharles M, Goldenberg D, Hauser W, Katz R . Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011; 38(6):1113-22. DOI: 10.3899/jrheum.100594. View

Gammoh O, Al-Smadi A, Tayfur M, Al-Omari M, Al-Katib W, Zein S . Syrian female war refugees: preliminary fibromyalgia and insomnia screening and treatment trends. Int J Psychiatry Clin Pract. 2020; 24(4):387-391. DOI: 10.1080/13651501.2020.1776329. View

Vandvik P, Lydersen S, Farup P . Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006; 41(6):650-6. DOI: 10.1080/00365520500442542. View

10.

Yang T, Chen C, Lin C, Lin W, Kuo C, Kao C . Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study. Medicine (Baltimore). 2017; 96(14):e6657. PMC: 5411228. DOI: 10.1097/MD.0000000000006657. View

11.

Bair M, Krebs E . Fibromyalgia. Ann Intern Med. 2020; 172(5):ITC33-ITC48. DOI: 10.7326/AITC202003030. View

12.

Nakamura I, Nishioka K, Usui C, Osada K, Ichibayashi H, Ishida M . An epidemiologic internet survey of fibromyalgia and chronic pain in Japan. Arthritis Care Res (Hoboken). 2014; 66(7):1093-101. DOI: 10.1002/acr.22277. View

13.

Jones G, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane G . The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2014; 67(2):568-75. DOI: 10.1002/art.38905. View

14.

Schmidt-Wilcke T, Clauw D . Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011; 7(9):518-27. DOI: 10.1038/nrrheum.2011.98. View

15.

Chaaya M, Slim Z, Habib R, Arayssi T, Dana R, Hamdan O . High burden of rheumatic diseases in Lebanon: a COPCORD study. Int J Rheum Dis. 2012; 15(2):136-43. DOI: 10.1111/j.1756-185X.2011.01682.x. View

16.

Salaffi F, Di Carlo M, Farah S, Atzeni F, Buskila D, Ablin J . Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Rheumatology (Oxford). 2020; 59(10):3042-3049. DOI: 10.1093/rheumatology/keaa061. View

17.

White L, Birnbaum H, Kaltenboeck A, Tang J, Mallett D, Robinson R . Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008; 50(1):13-24. DOI: 10.1097/JOM.0b013e31815cff4b. View

18.

Moukaddem A, Chaaya M, Slim Z, Jaffa M, Sibai A, Uthman I . Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Lebanon. Int J Rheum Dis. 2015; 20(2):169-176. DOI: 10.1111/1756-185X.12701. View

19.

Fuller-Thomson E, Nimigon-Young J, Brennenstuhl S . Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey. Rheumatol Int. 2011; 32(4):853-62. DOI: 10.1007/s00296-010-1713-x. View

20.

Loge-Hagen J, Saele A, Juhl C, Bech P, Stenager E, Mellentin A . Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis. J Affect Disord. 2019; 245:1098-1105. DOI: 10.1016/j.jad.2018.12.001. View